TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Wall Street Coronavirus Lead
Play
JIM CRAMER

Ride the Rotation: Cramer's 'Mad Money' Recap (Thursday 6/25/20)

PRESS RELEASES

Amyris And Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand And Business Partnership

PRESS RELEASES

INVESTOR ALERT: Law Offices Of Howard G. Smith Announces Investigation Of Amyris, Inc. (AMRS) On Behalf Of Investors

PRESS RELEASES

Glancy Prongay & Murray LLP, A Leading Securities Fraud Law Firm, Announces Investigation Of Amyris, Inc. (AMRS) On Behalf Of Investors

PRESS RELEASES

Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5

PRESS RELEASES

Amyris And The Infectious Disease Research Institute Enter Into Exclusive License For Novel RNA Vaccine Platform, Beginning With COVID-19 Vaccine

PRESS RELEASES

Amyris And Arzeda Enter Into Development Collaboration Agreement

PRESS RELEASES

Kaskela Law LLC Announces Stockholder Investigation Of Amyris, Inc. (AMRS) And Encourages Long-Term Investors To Contact The Firm

PRESS RELEASES

The Law Offices Of Frank R. Cruz Announces Investigation Of Amyris, Inc. (AMRS) On Behalf Of Investors

PRESS RELEASES

Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed

PRESS RELEASES

Amyris' Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles' Day Sales

PRESS RELEASES

Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada

PRESS RELEASES

Amyris To Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today

PRESS RELEASES

Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020

PRESS RELEASES

LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc. For Patent Infringement And Trade Secret Misappropriation

PRESS RELEASES

Amyris To Present At H.C. Wainwright 22nd Annual Global Investment Conference On September 14, 2020

PRESS RELEASES

Amyris Scales First Fermentation-Based Cannabinoid

PRESS RELEASES

Amyris Appoints Sheila Shekar Pollak As Chief Marketing Officer Of Biossance

PRESS RELEASES

INVESTOR ALERT: Monteverde & Associates PC Announces An Investigation Of Amyris, Inc. - AMRS

PRESS RELEASES

SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.

PRESS RELEASES

Amyris And The Infectious Disease Research Institute Partner To Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application

PRESS RELEASES

Amyris To Host Second Quarter 2020 Financial Results Conference Call On August 6

PRESS RELEASES

INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

PRESS RELEASES

INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

PRESS RELEASES

Biossance Announces Clean Academy Impact Award And Partnership With Oceana